Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiora Pharmaceuticals (KPRX) Goodwill (2016 - 2021)

Kiora Pharmaceuticals' Goodwill history spans 6 years, with the latest figure at $3.6 million for Q3 2021.

  • For Q3 2021, Goodwill rose 137.97% year-over-year to $3.6 million; the TTM value through Sep 2021 reached $3.6 million, up 137.97%, while the annual FY2020 figure was $3.6 million, 137.97% up from the prior year.
  • Goodwill reached $3.6 million in Q3 2021 per KPRX's latest filing, roughly flat from $3.6 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $5.4 million in Q1 2017 to a low of $1.5 million in Q4 2017.
  • Average Goodwill over 5 years is $3.0 million, with a median of $1.5 million recorded in 2017.
  • The largest YoY upside for Goodwill was 256.37% in 2017 against a maximum downside of 71.94% in 2017.
  • A 5-year view of Goodwill shows it stood at $1.5 million in 2017, then changed by 0.0% to $1.5 million in 2018, then changed by 0.0% to $1.5 million in 2019, then skyrocketed by 137.97% to $3.6 million in 2020, then changed by 0.0% to $3.6 million in 2021.
  • Per Business Quant, the three most recent readings for KPRX's Goodwill are $3.6 million (Q3 2021), $3.6 million (Q2 2021), and $3.5 million (Q1 2021).